Literature DB >> 27272543

Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.

Yan Cao1, Yang Zhang, George Shih, Yan Zhang, Andrew Bohmart, Elizabeth M Hecht, Martin R Prince.   

Abstract

OBJECTIVES: The purpose of this study was to determine if renal function affects signal changes in the deep brain nuclei on unenhanced T1-weighted images after administration of linear gadolinium-based contrast agents (GBCAs).
METHODS: An electronic medical records search of 2 large medical centers identified 25 patients who received linear GBCA while on hemodialysis and had unenhanced T1-weighted images of the brain before and after. The dentate-to-cerebellar peduncle (DCP) ratio, globus pallidus-to-mid thalamus (GPT) ratio, and choroid plexus-to-nearby white matter ratio were measured and compared with 25 age/sex/GBCA exposure-matched control patients with normal or near-normal renal function (estimated glomerular filtration rate >60 mL/min per 1.73 m). Two additional control groups included 13 patients on hemodialysis without GBCA exposure and 13 age/sex-matched patients with estimated glomerular filtration rate greater than 60 mL/min per 1.73 m.
RESULTS: Hemodialysis patients (n = 25) with an average of 1.8 linear GBCA administrations had a 4.9% mean increase (1.00 ± 0.04 vs 1.05 ± 0.05; P < 0.001) in DCP, which was greater than the 1.6% change (0.99 ± 0.04 vs 1.00 ± 0.05; P = 0.08) observed in matched controls (P = 0.01). There was no significant signal change in the DCP ratio in the 13 hemodialysis patients (0.99 ± 0.04 vs 0.99 ± 0.04; P = 0.78) and 13 age/sex-matched patients (0.99 ± 0.02 vs 0.99 ± 0.03; P = 0.78) who did not receive GBCA. The hemodialysis patients had a baseline GPT that was higher than nondialysis patients (P < 0.001). However, the GPT change after GBCA administration was not significantly different from controls. Increased signal in the choroid plexus on unenhanced T1-weighted images after GBCA administration was noted in hemodialysis patients (0.72 ± 0.20 vs 0.86 ± 0.23; P = 0.006); however, a multivariate analysis showed this to be primarily related to hemodialysis (P = 0.003) with only a trend toward relating to GBCA exposure (P = 0.07).
CONCLUSIONS: Hemodialysis patients receiving linear GBCA have greater dentate nucleus signal increases on unenhanced T1-weighted images, suggesting that renal function may affect the rate of gadolinium accumulation in the brain after linear GBCA-enhanced magnetic resonance imaging.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27272543     DOI: 10.1097/RLI.0000000000000294

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  16 in total

Review 1.  An Introduction to Contrast-Enhanced Ultrasound for Nephrologists.

Authors:  Emily H Chang
Journal:  Nephron       Date:  2017-11-09       Impact factor: 2.847

Review 2.  Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.

Authors:  Carlo C Quattrocchi; Joana Ramalho; Aart J van der Molen; Àlex Rovira; Alexander Radbruch
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

3.  Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.

Authors:  Giorgio Conte; Lorenzo Preda; Emilia Cocorocchio; Sara Raimondi; Caterina Giannitto; Marta Minotti; Francesca De Piano; Giuseppe Petralia; Pier Francesco Ferrucci; Massimo Bellomi
Journal:  Eur Radiol       Date:  2017-03-29       Impact factor: 5.315

4.  Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.

Authors:  S Dogra; M J Borja; Y W Lui
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-25       Impact factor: 3.825

5.  Contrast-Free Detection of Focused Ultrasound-Induced Blood-Brain Barrier Opening Using Diffusion Tensor Imaging.

Authors:  Maria Eleni Karakatsani; Antonios N Pouliopoulos; Michael Liu; Sachin R Jambawalikar; Elisa E Konofagou
Journal:  IEEE Trans Biomed Eng       Date:  2021-07-16       Impact factor: 4.756

6.  The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.

Authors:  Cyprian Olchowy; Kamil Cebulski; Mateusz Łasecki; Radosław Chaber; Anna Olchowy; Krzysztof Kałwak; Urszula Zaleska-Dorobisz
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

7.  Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats.

Authors:  Marlène Rasschaert; Jean-Marc Idée; Philippe Robert; Nathalie Fretellier; Véronique Vives; Xavier Violas; Sébastien Ballet; Claire Corot
Journal:  Invest Radiol       Date:  2017-05       Impact factor: 6.016

8.  Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.

Authors:  Marlène Rasschaert; Andréa Emerit; Nathalie Fretellier; Cécile Factor; Philippe Robert; Jean-Marc Idée; Claire Corot
Journal:  Invest Radiol       Date:  2018-06       Impact factor: 6.016

Review 9.  Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization-A Joint Initiative.

Authors:  Philippe Robert; Thomas Frenzel; Cécile Factor; Gregor Jost; Marlène Rasschaert; Gunnar Schuetz; Nathalie Fretellier; Janina Boyken; Jean-Marc Idée; Hubertus Pietsch
Journal:  Invest Radiol       Date:  2018-09       Impact factor: 6.016

Review 10.  Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates.

Authors:  Robert J McDonald; Deborah Levine; Jeffrey Weinreb; Emanuel Kanal; Matthew S Davenport; James H Ellis; Paula M Jacobs; Robert E Lenkinski; Kenneth R Maravilla; Martin R Prince; Howard A Rowley; Michael F Tweedle; Herbert Y Kressel
Journal:  Radiology       Date:  2018-09-11       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.